vs
CISO Global, Inc.（CISO）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
Foghorn Therapeutics Inc.的季度营收约是CISO Global, Inc.的1.5倍（$9.2M vs $6.3M），CISO Global, Inc.净利率更高（-35.4% vs -234.3%，领先198.9%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -15.4%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -11.6%）
CISO Global Inc.是专业网络安全服务商，提供托管安全监测、风险评估、合规咨询、事件响应、终端防护等服务，面向北美市场的中小企业、政府机构及商业客户，覆盖医疗、零售、金融等领域，助力客户保护数字资产、抵御网络风险。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
CISO vs FHTX — 直观对比
营收规模更大
FHTX
是对方的1.5倍
$6.3M
营收增速更快
FHTX
高出239.1%
-15.4%
净利率更高
CISO
高出198.9%
-234.3%
两年增速更快
FHTX
近两年复合增速
-11.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.3M | $9.2M |
| 净利润 | $-2.2M | $-21.7M |
| 毛利率 | 28.6% | — |
| 营业利润率 | -33.7% | -258.2% |
| 净利率 | -35.4% | -234.3% |
| 营收同比 | -15.4% | 223.8% |
| 净利润同比 | 59.8% | -11.1% |
| 每股收益（稀释后） | $0.10 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CISOFHTX
| Q4 25 | $6.3M | $9.2M | ||
| Q3 25 | $6.5M | $8.2M | ||
| Q2 25 | $6.7M | $7.6M | ||
| Q1 25 | $7.2M | $6.0M | ||
| Q4 24 | $7.4M | $2.9M | ||
| Q3 24 | $7.5M | $7.8M | ||
| Q2 24 | $7.8M | $6.9M | ||
| Q1 24 | $8.0M | $5.0M |
净利润CISOFHTX
| Q4 25 | $-2.2M | $-21.7M | ||
| Q3 25 | $2.5M | $-15.8M | ||
| Q2 25 | $-3.0M | $-17.9M | ||
| Q1 25 | $-5.4M | $-18.8M | ||
| Q4 24 | $-5.5M | $-19.5M | ||
| Q3 24 | $-3.7M | $-19.1M | ||
| Q2 24 | $-8.4M | $-23.0M | ||
| Q1 24 | $-6.6M | $-25.0M |
毛利率CISOFHTX
| Q4 25 | 28.6% | — | ||
| Q3 25 | 24.9% | — | ||
| Q2 25 | 24.4% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 24.8% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.8% | — |
营业利润率CISOFHTX
| Q4 25 | -33.7% | -258.2% | ||
| Q3 25 | -40.8% | -226.9% | ||
| Q2 25 | -34.7% | -279.2% | ||
| Q1 25 | -23.9% | -385.0% | ||
| Q4 24 | -26.1% | -840.5% | ||
| Q3 24 | -46.8% | -305.5% | ||
| Q2 24 | -54.3% | -386.6% | ||
| Q1 24 | -61.0% | -558.3% |
净利率CISOFHTX
| Q4 25 | -35.4% | -234.3% | ||
| Q3 25 | 39.2% | -194.4% | ||
| Q2 25 | -44.8% | -237.3% | ||
| Q1 25 | -75.1% | -316.4% | ||
| Q4 24 | -74.5% | -682.9% | ||
| Q3 24 | -49.0% | -244.9% | ||
| Q2 24 | -108.0% | -333.6% | ||
| Q1 24 | -82.4% | -495.4% |
每股收益（稀释后）CISOFHTX
| Q4 25 | $0.10 | $-0.35 | ||
| Q3 25 | $-0.05 | $-0.25 | ||
| Q2 25 | $-0.09 | $-0.28 | ||
| Q1 25 | $-0.38 | $-0.30 | ||
| Q4 24 | $-0.47 | $-0.23 | ||
| Q3 24 | $-0.32 | $-0.31 | ||
| Q2 24 | $-0.69 | $-0.45 | ||
| Q1 24 | $-0.55 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $80.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $14.8M | $-108.5M |
| 总资产 | $25.0M | $198.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CISOFHTX
| Q4 25 | $1.7M | $80.9M | ||
| Q3 25 | $1.1M | $89.3M | ||
| Q2 25 | $760.8K | $72.6M | ||
| Q1 25 | $1.8M | $61.0M | ||
| Q4 24 | $992.6K | $55.5M | ||
| Q3 24 | $443.1K | $57.7M | ||
| Q2 24 | $1.1M | $138.9M | ||
| Q1 24 | $1.5M | $79.3M |
总债务CISOFHTX
| Q4 25 | — | — | ||
| Q3 25 | $2.1M | — | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $11.9M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $15.1M | — |
股东权益CISOFHTX
| Q4 25 | $14.8M | $-108.5M | ||
| Q3 25 | $16.3M | $-89.7M | ||
| Q2 25 | $7.6M | $-76.7M | ||
| Q1 25 | $7.0M | $-61.7M | ||
| Q4 24 | $1.1M | $-45.5M | ||
| Q3 24 | $3.0M | $-28.3M | ||
| Q2 24 | $5.6M | $-14.3M | ||
| Q1 24 | $11.2M | $-97.5M |
总资产CISOFHTX
| Q4 25 | $25.0M | $198.1M | ||
| Q3 25 | $25.1M | $205.0M | ||
| Q2 25 | $25.8M | $226.2M | ||
| Q1 25 | $27.8M | $258.7M | ||
| Q4 24 | $26.7M | $284.0M | ||
| Q3 24 | $26.6M | $308.4M | ||
| Q2 24 | $43.2M | $328.6M | ||
| Q1 24 | $47.5M | $255.0M |
负债/权益比CISOFHTX
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 1.52× | — | ||
| Q4 24 | 10.20× | — | ||
| Q3 24 | 3.92× | — | ||
| Q2 24 | 2.27× | — | ||
| Q1 24 | 1.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CISOFHTX
| Q4 25 | $-1.8M | $-22.3M | ||
| Q3 25 | $-876.7K | $-18.9M | ||
| Q2 25 | $-2.3M | $-21.0M | ||
| Q1 25 | $-3.0M | $-24.0M | ||
| Q4 24 | $-259.0K | $-24.5M | ||
| Q3 24 | $-903.1K | $-21.0M | ||
| Q2 24 | $-1.3M | $-25.5M | ||
| Q1 24 | $-1.4M | $-29.3M |
自由现金流CISOFHTX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | $-1.3M | $-25.6M | ||
| Q1 24 | $-1.5M | $-29.4M |
自由现金流率CISOFHTX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | -16.4% | -371.0% | ||
| Q1 24 | -18.5% | -583.1% |
资本支出强度CISOFHTX
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 0.0% | 16.8% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.9% | 2.0% |
现金转化率CISOFHTX
| Q4 25 | — | — | ||
| Q3 25 | -0.35× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CISO
| Security Managed Services | $5.4M | 87% |
| Other | $823.3K | 13% |
FHTX
暂无分部数据
